Three decades of advances in diabetes care have transformed how people with type 1 diabetes manage glucose. Insulin pumps, continuous glucose monitoring (CGM), improved insulin analogs, automated insulin delivery, and earlier screening have all changed daily treatment. However, have these advances actually reduced the long-term complications of type 1 diabetes? …
Read More »Your Insulin Pump Is Learning Your Habits: How AI Is Quietly Changing Diabetes Care
Artificial intelligence is entering diabetes care in a surprisingly quiet way. Rather than appearing as a chatbot or separate decision-support tool, increasingly sophisticated algorithms are being built into automated insulin delivery systems. Adaptive insulin pump hardware can work with continuous glucose monitor (CGM) data, recent insulin delivery, and changing glucose …
Read More »Can Bi-Hormonal Systems Finally Eliminate Severe Hypoglycemia?
Many people with type 1 diabetes live with the constant fear of blood glucose dropping too low. Even today’s most advanced automated insulin delivery systems cannot actively raise glucose once levels begin to fall. Instead, they can only reduce or suspend insulin delivery. A dual-hormone artificial pancreas system changes that …
Read More »Could “Smart” Insulin End Hypoglycemia? The Race Toward Glucose-Responsive Therapy
For more than a century, insulin has saved millions of lives. Yet despite remarkable advances in diabetes technology, one major challenge remains: preventing hypoglycemia while maintaining excellent glucose control. That is why researchers are developing glucose-responsive insulin, often called “smart” insulin. Instead of delivering a fixed amount of insulin regardless …
Read More »Why Some Patients Wait Months for Automated Insulin Delivery—and How to Avoid It
For many people living with diabetes, gaining access to an automated insulin delivery (AID) system can be life-changing. These technologies help improve glycemic outcomes, reduce hypoglycemia risk, and ease the daily burden of diabetes management. Yet despite their proven benefits, many patients continue to face lengthy delays before gaining access. …
Read More »Should Hospitalized Patients Keep Their CGMs and Insulin Pumps? The 2026 Standards Say Yes
For years, hospital admission often meant disconnecting patients from their personal diabetes devices. Continuous glucose monitors (CGMs) and insulin pumps were frequently removed, even when patients had used them successfully at home. However, the 2026 American Diabetes Association (ADA) Standards of Care introduce a significant shift in how hospitals approach …
Read More »Ultra-Rapid Insulin and Automated Delivery: Are Mealtime Boluses Becoming Less Critical?
For years, diabetes care has relied on one key rule: insulin should be given before meals whenever possible. Yet many people living with diabetes still struggle with timing. Busy schedules, unpredictable eating habits, and delayed dosing often lead to postprandial glucose spikes. Now, with the rise of ultra-rapid insulin AID …
Read More »Open-Source Diabetes Technology Is Entering the Mainstream: Are Clinicians Ready?
The conversation around DIY diabetes technology and patient-led insulin automation has changed dramatically over the past few years. What once existed on the margins of diabetes care is now gaining recognition from major medical organizations and healthcare providers. In fact, the 2026 American Diabetes Association (ADA) Standards of Care continue …
Read More »The New Pregnancy Tech Era in Diabetes: How Automated Insulin Delivery Is Expanding Into Maternal Care
The management of type 1 diabetes during pregnancy is entering a major turning point. For years, endocrinologists and maternal-fetal medicine specialists have worked within narrow therapeutic margins to reduce maternal and neonatal complications. However, new advances in automated insulin delivery technology for pregnancy are beginning to reshape glucose management in …
Read More »Automated Insulin Delivery Is Expanding Into Type 2 Diabetes: Are Primary Care Practices Ready?
Automated insulin delivery for people with type 2 diabetes is entering a new phase. What once seemed reserved for highly specialized endocrinology clinics is now moving steadily into primary care offices across the country. Following the updated 2026 American Diabetes Association Standards of Care and recent FDA clearances, more adults …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.